Tag Archives: Patients

Just 2% of Patients Who Need It Get Anti-Opioid Drug Naloxone

FRIDAY, Jan. 17, 2020 — Naloxone can prevent opioid overdose deaths, but only a tiny percentage of Americans at risk are prescribed the lifesaving drug. That’s the key finding from an analysis of nationwide data on adults with private health insurance. The researchers found that while naloxone (Evzio, Narcan) prescriptions in this group rose between… Read More »

How A ‘Care Ecosystem’ Supports Dementia Patients And Caregivers

By George Lorenzo, Next Avenue Contributor Helen Medsger and her sister, Maureen Shaw, participated in UCSF’s Care Ecosystem program Courtesy of Helen Medsger In recent years, we’ve seen a greater awareness in the U.S. and the world about the increasing number of people with Alzheimer’s disease and other dementias. And we’ve learned a lot more… Read More »

FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients

FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients Print this page December 23, 2019 — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) today announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for its in-house discovered and developed orexin receptor antagonist Dayvigo (lemborexant). Dayvigo… Read More »

Acadia Pharma’s psychosis drug proven better than placebo in dementia patients

(Reuters) – Acadia Pharmaceuticals Inc said on Wednesday dementia patients taking its drug Nuplazid were nearly three times less prone to a psychotic relapse than those on placebo. The drugmaker’s late-stage trial testing Nuplazid, stopped in September after positive results, enrolled 392 patients aged 74.5 years on average. Patients on the drug experienced a 65%… Read More »